QRxPharma Successfully Completes Comparative Study for Dual-Opioid(TM) Pain Therapy
... well as provide sample size guidance for the upcoming Phase 3 Combination rule study required for NDA submission in 2010. "Having achieved ... "From these data, we are confident that our upcoming Phase 3 Combination rule study will prove successful." In this randomized, double blind study ...Prometheus Announces New Findings Regarding Patients at Risk for Celiac Disease at DDW
... Blood and serum samples were analyzed using PROMETHEUS(R) Celiac PLUS and PROMETHEUS(R) IBD Serology 7 diagnostic tests. "Genetic tests to rule out celiac disease are now readily available. However, few genetically predisposed individuals actually develop the disease, despite gluten ...Spherix Elects New Independent Director, and Elects Chairman of the Board
... introductions. With the election of Mr. Peter to Spherix's Board, the Company has notified NASDAQ that it has regained compliance with NASDAQ's rule that requires a majority of the board of directors be independent directors. In related news, Spherix's Board also elected Dr. Robert J. Vander ...Lack of Food Variety Puts Kids With Autism at Risk for Poor Nutrition
... are functional issues in neural cells involving a deficiency of essential fatty acids," said Dr. Zimmer. "The main point of the study is we cannot rule that fatty acids are part of the story of what is going on with kids who have autism." Dr. Zimmer said its possible older children with autism ...Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
... A majority of Advisory Committee members supported that appropriate evidence of cardiovascular safety had been provided to rule out excess cardiovascular risk of liraglutide relative to comparators. While a majority of Advisory Committee members did not find that Novo ...DOR BioPharma, Inc. Executes $400,000 Equity Investment Agreement With Numoda Corporation
... This press release does not and will not constitute an offer to sell or the solicitation of an offer to buy shares and is being issued under rule 135c under the Securities Act. About Numoda Corporation Numoda Corporation is a leading provider of services to promising life sciences ...Neuralstem's Human Stem Cells Integrate into Nervous System of Rats with Animal Model of ALS
... These rats received live-cell grafts or dead-cell grafts as controls. In addition, four healthy rats (Spague-Dawley) received live-cell grafts to rule out whether or not any cell activity could be attributed solely to ALS in the SOD-1 rats. The rats had been injected with a tracing material to track ...Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials
... the United States. The resale or transfer by a U.S. investor of such common shares of Bradmer Pharmaceuticals Inc. is subject to the requirements of rule 904 of Regulation S of the Securities Act or such other applicable exemption thereunder, and other applicable state securities laws. Except for ...AstraZeneca Submits sNDA for NEXIUM(R) I.V. for Peptic Ulcer Bleed Indication
... four to eight weeks. Individual results may vary, and only a doctor can determine if erosions to the esophagus have occurred. Symptom relief does not rule out the existence of other serious stomach conditions. NEXIUM received approval in April 2006 for the short-term treatment (up to 8 weeks) of GERD ...Study Finds QIAGEN's HPV Test Offers Greater Long-term Protection From Cervical Disease Than the Pap
... April 1994 to September 1997 at 40 different general-medicine practices in the United Kingdom. A colposcopy exam and biopsy were used to confirm or rule out the presence of cervical disease after each woman had both the HPV test and a conventional Pap. The sensitivity of the digene HPV Test was 96 ...Studies Show Body Mass Index Has No Effect on Resolution and Healing of GERD Symptoms
... do not extend beyond 6 months. Common side effects with NEXIUM include headache, diarrhea, and abdominal pain. Symptom relief does not rule out other serious stomach conditions. AstraZeneca is committed to helping people get the medicines they need. In 2006, 97,614 NEXIUM patients were ...Optimizing Quality Control Data Management
... comparison The Westgard Advisor Automatic rule Selection Algorithm The Westgard Advisor ... rules. The system provides 17 different rule options that can be set to reject, warn or off. ... a bi-directional interface that communicates rule evaluations to other systems. Laboratories may ...Appendicitis: Evolving Tools to Diagnose a Classic Disease
... mimic appendicitis, and it is often difficult to rule it out based on clinical presentation. This is ... No feature on physical exam has been proven to rule out appendicitis definitively. Fortunately, a ... provide optimal ,i>negative predictive value to rule out appendicitis with confidence and avoid ...Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
... shares of Sunesis common stock, effective June 29, 2007. These option awards were granted without shareholder approval pursuant to Nasdaq Marketplace rule 4350 (i)(1)(A)(iv) and with the following material terms: (a) an exercise price equal to the fair market value of the company's common stock on the ...Molecular Target of Bradmer's Neuradiab Further Validated by Independent Findings
... the United States. The resale or transfer by a U.S. investor of such common shares of Bradmer Pharmaceuticals Inc. is subject to the requirements of rule 904 of Regulation S of the Securities Act or such other applicable exemption thereunder, and other applicable state securities laws. Except for ...Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
... analyzer is found at the center of most clinical laboratories. A blood cell count is usually the first screening test used to assess general health, rule out anemia or infection, and monitor cancer patients during the course of chemotherapy. It is difficult to imagine medical care without this ...Avian (Bird) Flu: Is There a Role for Rapid Tests?
... An equally important question is the negative predictive value of rapid tests. The WHO points out that a negative result on a rapid test does not rule out avian flu infection. Obviously, failure to detect even one infected person could have disastrous public health consequences. For areas where ...New Assays to Detect Disseminated Fungal Infections
... of 1.7%. It nevertheless demonstrated a negative predictive value of 93% in this sample. The results imply that Syscan 3 is relatively useful to rule out disseminated candidiasis. PCR assays will soon be available for Candida and Aspergillus . And lest it seem difficult to select one of ...West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
... 3 hours and 45 minutes. Positive samples must be tested with the background subtract procedure (either on the initial test or on a repeat test) to rule out false positives caused by rheumatoid factor and heterophilic antibodies. The IgG ELISA utilizes wells coated with recombinant WNV antigen to ...Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse
... category, several firms produce test kits that can be used in point of care settings to monitor drug free status or in the pre-employment setting to rule out illegal drug use. A1 UA Test Kits from Transmetron, Salt Lake City, Utah, are based in a self-contained urinalysis drug test process that ...